Sanctuary Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Sell
6,590
-7,774
-54% -$4.36M 0.02% 744
2026
Q1
$8.07M Buy
14,364
+1,628
+13% +$1.04M 0.04% 428
2025
Q4
$8.62M Buy
12,736
+7,186
+129% +$4.89M 0.05% 396
2025
Q3
$3.55M Buy
5,550
+1,094
+25% +$664K 0.02% 648
2025
Q2
$2.39M Buy
4,456
+1,561
+54% +$746K 0.01% 765
2025
Q1
$1.22M Sell
2,895
-35
-1% -$15.2K 0.01% 1040
2024
Q4
$1.24M Sell
2,930
-358
-11% -$157K 0.01% 1126
2024
Q3
$1.37M Buy
3,288
+558
+20% +$271K 0.01% 1093
2024
Q2
$1.36M Buy
+2,730
New +$1.37M 0.01% 1019

Other funds holding IDXX

Sanctuary Advisors's IDXX Position: Q2 2026 in Review

Sanctuary Advisors reduced its Idexx Laboratories (IDXX) stake by 54% in Q2 2026, selling an estimated $4.36M and leaving 6,590 shares worth $3.47M. The position accounts for 0.02% of the portfolio, ranked #744.

Sanctuary Advisors first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.62M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sanctuary Advisors held 6,590 shares of Idexx Laboratories worth $3.47M as of Q2 2026.
  • Sanctuary Advisors sold 7,774 Idexx Laboratories shares in Q2 2026, an estimated $4.36M.
  • Idexx Laboratories made up 0.02% of Sanctuary Advisors's portfolio in Q2 2026, its #744 holding.
  • Sanctuary Advisors first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Idexx Laboratories position peaked at $8.62M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.